MCB has been the topic of a number of other research reports. Liberum Capital reissued a buy rating and issued a GBX 260 ($3.53) price target on shares of McBride in a research report on Monday. Numis Securities lifted their price target on shares of McBride from GBX 235 ($3.19) to GBX 260 ($3.53) and gave the company a buy rating in a research report on Wednesday, October 4th. Finally, Berenberg Bank lifted their price target on shares of McBride from GBX 220 ($2.98) to GBX 240 ($3.25) and gave the company a buy rating in a research report on Friday, September 29th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of Buy and an average target price of GBX 235 ($3.19).
McBride (LON MCB) traded down GBX 8.80 ($0.12) during trading hours on Monday, hitting GBX 186.20 ($2.53). 809,453 shares of the stock were exchanged, compared to its average volume of 162,465. McBride has a 12 month low of GBX 158.31 ($2.15) and a 12 month high of GBX 235 ($3.19). The company has a market capitalization of $339.51 and a price-to-earnings ratio of 3,724.00.
McBride plc is a provider of private label household and personal care products. The Company is engaged in developing, producing and supplying its products to retailers across Europe. Its segments include Household, Personal Care & Aerosols (PCA) and Corporate. The Household segment consists of UK; North, including France, Belgium, Holland and Scandinavia; South, including Italy and Spain, and East, including Germany, Poland, Luxembourg and other Eastern Europe.
What are top analysts saying about McBride? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for McBride and related companies.